
Understanding the role of natriuretic peptides and SGLT2 inhibition in HFpEF treatment.


coremsg

A new study adds to the evidence that NT-proBNP levels are strong prognostic markers of clinical severity in patients with HFpEF, and may inform potential for treatment response to SGLT2 inhibitors.

Natriuretic Peptides and Potential Treatment Response in HFpEF

natriuretic-peptides-and-sglt2-inhibition-in-hfpef-treatment


Natriuretic Peptides and SGLT2 Inhibition in HFpEF Treatment
